Comparative Effectiveness of Neuromodulation Techniques for Managing Neurogenic Bladder in Women with MS
Recent research has explored the use of neuromodulation methods to treat neurogenic overactive bladder symptoms in women diagnosed with multiple sclerosis (MS). Two primary techniques, transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS), have demonstrated similar levels of effectiveness in managing bladder dysfunction.
A pilot study published online on April 11 in Neurodegenerative Disease Management involved 16 female MS patients divided into two groups. Each group received one of the treatments over a period of two consecutive weeks, with a total of 10 sessions. The study aimed to assess the impact of these methods on bladder function through various urodynamic parameters and patient-reported measures.
Results indicated that neither TPTNS nor rTMS produced significant changes within or between groups regarding urodynamic parameters. However, notable improvement was observed in nocturia frequency in the TPTNS group when analyzing a three-day voiding diary. Other patient-centered assessments, including the Overactive Bladder Questionnaire-V8, Incontinence Severity Index, and Incontinence Quality of Life Scale, showed no significant differences.
The authors highlighted that both neuromodulation strategies are advantageous because they are safe, easy to administer, and free of side effects. Consequently, both TPTNS and rTMS are considered viable treatment options for women with MS experiencing neurogenic bladder symptoms.
These findings suggest that neuromodulation could be a promising avenue for symptom relief, although further research with larger sample sizes is needed to confirm long-term benefits. The study underscores the importance of patient safety and treatment accessibility in managing complex neurogenic conditions.
For more information, see the full study: Pınar Atak Çakir et al, Effect of neuromodulation on neurogenic bladder in women with multiple sclerosis: a pilot randomized controlled trial, Neurodegenerative Disease Management (2025). [DOI: 10.1080/17582024.2025.2488712].
Source: https://medicalxpress.com/news/2025-05-neuromodulation-methods-outcomes-neurogenic-bladder.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advances in Gene Therapy: New Insights into Genome Ejection Mechanisms of AAV Vectors
New research from the University of Osaka uncovers the molecular mechanisms of genome ejection in AAV vectors, offering promising avenues for improved gene therapy vector design and safety.
New ESC/EAS Guidelines Introduce Enhanced Strategies for Cardiovascular Risk Assessment and Lipid Management
The latest ESC/EAS guidelines introduce improved cardiovascular risk prediction tools and treatment strategies, including statins for high-risk groups, to enhance lipid management and prevent cardiovascular disease.
Over 10% of Surgical Patients Experience Food Insecurity
A recent study reveals that over 10% of surgical patients in the U.S. face food insecurity, highlighting the need for targeted interventions to improve patient outcomes.
Bariatric Surgery May Improve Outcomes for Obese Patients with Inflammatory Bowel Disease
New research reveals that bariatric surgery can significantly improve inflammatory bowel disease outcomes in obese patients, offering a promising integrated treatment approach.